Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to clinical outcomes
View ORCID ProfileGemma Modinos, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Nicolas Crossley, Jesus Perez, James M. Stone, Mattia Veronese, Fernando Zelaya, Anthony A Grace, Oliver D Howes, Paul Allen, Philip McGuire
doi: https://doi.org/10.1101/2020.12.08.20245902
Gemma Modinos
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
2Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
3MRC Centre for Neurodevelopmental Disorders, King’s College London, UK
PhDAnja Richter
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
PhDAlice Egerton
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
PhDIlaria Bonoldi
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
MDMatilda Azis
4Department of Psychology, Northwestern University, Chicago, IL, USA
PhDMathilde Antoniades
5Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
PhDMatthijs Bossong
6Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands
PhDNicolas Crossley
7Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
MD PhDJesus Perez
8CAMEO Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK
9Department of Psychiatry, University of Cambridge, Cambridge, UK
10Department of Neuroscience, Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
MDJames M. Stone
2Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
13South London and Maudsley Foundation NHS Trust, Maudsley Hospital, London, UK
MD PhDMattia Veronese
2Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
PhDFernando Zelaya
2Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
PhDAnthony A Grace
11Departments of Neuroscience, Psychiatry and Psychology, University of Pittsburgh, Pittsburgh PA, USA
PhDOliver D Howes
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
3MRC Centre for Neurodevelopmental Disorders, King’s College London, UK
12MRC London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital, London, UK
13South London and Maudsley Foundation NHS Trust, Maudsley Hospital, London, UK
MD PhDPaul Allen
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
14Department of Psychology, University of Roehampton, UK
PhDPhilip McGuire
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
3MRC Centre for Neurodevelopmental Disorders, King’s College London, UK
13South London and Maudsley Foundation NHS Trust, Maudsley Hospital, London, UK
MD PhD
Posted December 11, 2020.
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to clinical outcomes
Gemma Modinos, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Nicolas Crossley, Jesus Perez, James M. Stone, Mattia Veronese, Fernando Zelaya, Anthony A Grace, Oliver D Howes, Paul Allen, Philip McGuire
medRxiv 2020.12.08.20245902; doi: https://doi.org/10.1101/2020.12.08.20245902
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to clinical outcomes
Gemma Modinos, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Nicolas Crossley, Jesus Perez, James M. Stone, Mattia Veronese, Fernando Zelaya, Anthony A Grace, Oliver D Howes, Paul Allen, Philip McGuire
medRxiv 2020.12.08.20245902; doi: https://doi.org/10.1101/2020.12.08.20245902
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)